Table 9.
Outcome | Dimension | Number of studies/ population members | Average effectivenessa, % | Duration, % | Frequency, % | |||
Short (<1 month) |
Long (≥1 month) |
Highb | Lowc | |||||
Satisfaction | Information provided | 7/1320 | 93 | 88 | 100 | 88 | 100 | |
Satisfaction | Overall care | 8/1915 | 64 | 72 | 52 | 72 | 52 | |
Adherence | Instructions | 8/2032 | 75 | 72 | 100 | 75 | N/Ad | |
Adherence | Medication usage | 3/541 | 84 | N/A | 84 | 50 | 100 | |
Quality of life | Overall | 7/1300 | 48 | 100 | 38 | 66 | 57 | |
Clinical parameters | Physical functioning and pain | 4/836 | 50 | 89 | 30 | 89 | 30 | |
Clinical parameters | Clinical values | 4/913 | 74 | 76 | 50 | 76 | 50 | |
Clinical parameters | Symptoms | 3/315 | 39 | N/A | 39 | 100 | 0 | |
Health care economics | Overall | 5/860 | 59 | 78 | 68 | 78 | 68 | |
Knowledge | Overall | 4/634 | 100 | 100 | 100 | 100 | 100 | |
Average effect | N/A | N/A | 69 | 82 | 69 | 78 | 64 |
aAverage effectiveness is the weighted average of the population linked to an outcome and the part of the population with a positive effect on the outcome.
bHigh frequency is >1 message per week, on average.
cLow frequency is ≤1 message per week, on average.
dN/A: not applicable.